Is it possible to separate ischemic and bleeding risk in patients with non-ST segment elevation acute coronary syndromes?

Abstract

Both intensive antithrombotic therapy and an early invasive strategy reduce the incidence of ischemic events in patients with non-ST segment elevation acute coronary syndromes (NSTE-ACS), at the expense of increasing the rate of bleeding complications. Current recommendations [1] emphasize the use of an early invasive strategy in patients at higher risk. However, most registries show a more conservative management in these patients